Pseudokinase STK40 promotes T H 1 and T H 17 cell differentiation by targeting FOXO transcription factors
Science Advances · 22.11.2024 · 10 (47)
DOI: 10.1126/sciadv.adp2919 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 22.11.2024. Verfasst von Yuexiao Tao und 17 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immune-Related Diseases at Shanghai Institute of Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine; Hongqiao I…. Hauptthemen laut MEDLINE: Th17 Cells, Th1 Cells, Protein Serine-Threonine Kinases, Cell Differentiation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Inappropriate CD4 + T helper (T H ) cell differentiation leads to progression of inflammatory and autoimmune diseases, yet the regulatory mechanisms governing stability and activity of transcription factors controlling T H cell differentiation remain elusive. Here, we describe how pseudokinase serine threonine kinase 40 (STK40) facilitates T H 1/T H 17 differentiation under pathological conditions. STK40 in T cells is dispensable for immune homeostasis in resting mice. However, mice with T cell–specific deletion of STK40 exhibit attenuated symptoms of experimental autoimmune encephalomyelitis and colitis, accompanied by diminished T H 1 and T H 17 cell differentiation. Mechanistically, STK40 facilitates K48-linked polyubiquitination and proteasomal degradation of FOXO1/4 through promoting their interaction with E3 ligase COP1. Inhibition of FOXO4 or FOXO1, respectively, restores differentiation potential of STK40-deficient T H 1/T H 17 cells. Together, our data suggest a crucial role of STK40 in T H 1 and T H 17 cell differentiation, thereby enabling better understanding of the molecular regulatory network of CD4 + T cell differentiation and providing effective targets for the treatment of autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Immune-Related Diseases at Shanghai Institute of Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine; Hongqiao International Institute of Medicine, Shanghai Tongren Hospital, Shangha…
- Department of Histoembryology, Genetics and Developmental Biology, Shanghai Key Laboratory of Reproductive Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai 200031, China.
- Department of Gastroenterology, Hepatology, and Nutrition, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Yuexiao Tao, Xin Li, Jun Ni, Lina Wang, Bing Liao, Ting Zhang, Xuefeng Wu
Zitieren
APA
Tao, Y., Jiang, Z., Wang, H., Li, J., Li, X., Ni, J., Liu, J., Xiang, H., Guan, C., Cao, W., Li, D., He, K., Wang, L., Hu, J., Jin, Y., Liao, B., Zhang, T., & Wu, X. (2024). Pseudokinase STK40 promotes T H 1 and T H 17 cell differentiation by targeting FOXO transcription factors. Science Advances, 10(47). https://doi.org/10.1126/sciadv.adp2919
Vancouver
Tao Y, Jiang Z, Wang H, Li J, Li X, Ni J, et al. Pseudokinase STK40 promotes T H 1 and T H 17 cell differentiation by targeting FOXO transcription factors. Science Advances. 2024;10(47). doi:10.1126/sciadv.adp2919
BibTeX
@article{Tao2024,
author = {Tao, Yuexiao and Jiang, Zhenyan and Wang, Huizi and Li, Jia and Li, Xin and Ni, Jun and Liu, Jiamin and Xiang, Hongrui and Guan, Chenyang and Cao, Wei and Li, Dongyang and He, Ke and Wang, Lina and Hu, Jing and Jin, Ying and Liao, Bing and Zhang, Ting and Wu, Xuefeng},
title = {Pseudokinase STK40 promotes T H 1 and T H 17 cell differentiation by targeting FOXO transcription factors},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {47},
doi = {10.1126/sciadv.adp2919}
}
EUVIMED